ORFITEX-PD Syrup is an effective bronchodilator formulation from Orfit Pharmaceutical Pvt. Ltd., designed to provide quick and sustained relief from respiratory conditions involving airway constriction. It contains Salbutamol Sulphate (equivalent to Salbutamol 1 mg), a fast-acting beta-2 agonist, along with Etofyline 50 mg, a methylxanthine bronchodilator that helps improve airflow by relaxing bronchial muscles. This syrup is commonly used in the management of bronchial asthma, wheezing, chronic bronchitis, and other obstructive airway disorders, especially in pediatric patients. Salbutamol provides rapid relief from bronchospasm, while etofylline enhances bronchodilation and supports better lung function, helping to reduce breathlessness, chest tightness, and coughing. The liquid formulation allows accurate dosing and easy administration, making ORFITEX-PD particularly suitable for children and patients who have difficulty swallowing tablets. Manufactured under strict quality and safety standards, ORFITEX-PD reflects Orfit Pharmaceutical Pvt. Ltd.’s commitment to delivering safe, effective, and patient-friendly solutions for respiratory care.